High density lipoprotein turnover in patients with hypertension

Y. D Ida Chen, Wayne H H Sheu, Arthur L Swislocki, Gerald M. Reaven

Research output: Contribution to journalArticle

23 Citations (Scopus)

Abstract

Although hyperinsulinemia and decreased high density lipoprotein cholesterol concentration can occur in patients with hypertension, there is no information available concerning the dynamic state of high density lipoprotein metabolism. To address this issue, we quantified high density lipoprotein turnover in 12 patients with mild hypertension and 11 matched subjects with normal blood pressure. Patients with high blood pressure had lower high density lipoprotein cholesterol concentrations. Fractional catabolic rates of 125I-apolipoprotein AI (apoAI)/high density lipoprotein were faster in patients with hypertension (0.36±0.02 versus 0.26±0.02 I/day, p<0.001). Total synthetic rates of apoAI were also significantly greater in patients with high blood pressure (17.4±1.1 versus 13.2±0.6 mg/kg/day, p<0.001). Although significant correlation was observed between blood pressure and fractional catabolic rate of 125I-apoAI/high density lipoprotein in the experimental population (r=0.52, p<0.01), no relation was found when patients with normal blood pressure or hypertension were considered separately. However, a highly significant positive correlation was found between 125I-apoAI/high density lipoprotein fractional catabolic rate and insulin concentration in the entire population (r=0.72, p<0.001). In conclusion, the patients with mild hypertension studied were hyperinsulinemic, had a faster fractional catabolic rate of 125I-apoAI/high density lipoprotein, and a lower high density lipoprotein-cholesterol concentration. It is suggested that the changes seen in high density lipoprotein-cholesterol concentration and 125I-apoAI/high density lipoprotein fractional catabolic rates were secondary to the hyperinsulinemia and not due to the high blood pressure per se.

Original languageEnglish (US)
Pages (from-to)386-393
Number of pages8
JournalHypertension
Volume17
Issue number3
StatePublished - Mar 1991
Externally publishedYes

Fingerprint

HDL Lipoproteins
Apolipoprotein A-I
Hypertension
HDL Cholesterol
Hyperinsulinism
Blood Pressure
Apolipoproteins
Population
Insulin

Keywords

  • Apolipoproteins
  • Blood pressure
  • Essential hypertension
  • High density lipoprotein kinetics
  • High density lipoproteins
  • Hyperinsulinemia

ASJC Scopus subject areas

  • Internal Medicine

Cite this

Chen, Y. D. I., Sheu, W. H. H., Swislocki, A. L., & Reaven, G. M. (1991). High density lipoprotein turnover in patients with hypertension. Hypertension, 17(3), 386-393.

High density lipoprotein turnover in patients with hypertension. / Chen, Y. D Ida; Sheu, Wayne H H; Swislocki, Arthur L; Reaven, Gerald M.

In: Hypertension, Vol. 17, No. 3, 03.1991, p. 386-393.

Research output: Contribution to journalArticle

Chen, YDI, Sheu, WHH, Swislocki, AL & Reaven, GM 1991, 'High density lipoprotein turnover in patients with hypertension', Hypertension, vol. 17, no. 3, pp. 386-393.
Chen, Y. D Ida ; Sheu, Wayne H H ; Swislocki, Arthur L ; Reaven, Gerald M. / High density lipoprotein turnover in patients with hypertension. In: Hypertension. 1991 ; Vol. 17, No. 3. pp. 386-393.
@article{246d00a5427b424ba3def4dbb99f0e3f,
title = "High density lipoprotein turnover in patients with hypertension",
abstract = "Although hyperinsulinemia and decreased high density lipoprotein cholesterol concentration can occur in patients with hypertension, there is no information available concerning the dynamic state of high density lipoprotein metabolism. To address this issue, we quantified high density lipoprotein turnover in 12 patients with mild hypertension and 11 matched subjects with normal blood pressure. Patients with high blood pressure had lower high density lipoprotein cholesterol concentrations. Fractional catabolic rates of 125I-apolipoprotein AI (apoAI)/high density lipoprotein were faster in patients with hypertension (0.36±0.02 versus 0.26±0.02 I/day, p<0.001). Total synthetic rates of apoAI were also significantly greater in patients with high blood pressure (17.4±1.1 versus 13.2±0.6 mg/kg/day, p<0.001). Although significant correlation was observed between blood pressure and fractional catabolic rate of 125I-apoAI/high density lipoprotein in the experimental population (r=0.52, p<0.01), no relation was found when patients with normal blood pressure or hypertension were considered separately. However, a highly significant positive correlation was found between 125I-apoAI/high density lipoprotein fractional catabolic rate and insulin concentration in the entire population (r=0.72, p<0.001). In conclusion, the patients with mild hypertension studied were hyperinsulinemic, had a faster fractional catabolic rate of 125I-apoAI/high density lipoprotein, and a lower high density lipoprotein-cholesterol concentration. It is suggested that the changes seen in high density lipoprotein-cholesterol concentration and 125I-apoAI/high density lipoprotein fractional catabolic rates were secondary to the hyperinsulinemia and not due to the high blood pressure per se.",
keywords = "Apolipoproteins, Blood pressure, Essential hypertension, High density lipoprotein kinetics, High density lipoproteins, Hyperinsulinemia",
author = "Chen, {Y. D Ida} and Sheu, {Wayne H H} and Swislocki, {Arthur L} and Reaven, {Gerald M.}",
year = "1991",
month = "3",
language = "English (US)",
volume = "17",
pages = "386--393",
journal = "Hypertension",
issn = "0194-911X",
publisher = "Lippincott Williams and Wilkins",
number = "3",

}

TY - JOUR

T1 - High density lipoprotein turnover in patients with hypertension

AU - Chen, Y. D Ida

AU - Sheu, Wayne H H

AU - Swislocki, Arthur L

AU - Reaven, Gerald M.

PY - 1991/3

Y1 - 1991/3

N2 - Although hyperinsulinemia and decreased high density lipoprotein cholesterol concentration can occur in patients with hypertension, there is no information available concerning the dynamic state of high density lipoprotein metabolism. To address this issue, we quantified high density lipoprotein turnover in 12 patients with mild hypertension and 11 matched subjects with normal blood pressure. Patients with high blood pressure had lower high density lipoprotein cholesterol concentrations. Fractional catabolic rates of 125I-apolipoprotein AI (apoAI)/high density lipoprotein were faster in patients with hypertension (0.36±0.02 versus 0.26±0.02 I/day, p<0.001). Total synthetic rates of apoAI were also significantly greater in patients with high blood pressure (17.4±1.1 versus 13.2±0.6 mg/kg/day, p<0.001). Although significant correlation was observed between blood pressure and fractional catabolic rate of 125I-apoAI/high density lipoprotein in the experimental population (r=0.52, p<0.01), no relation was found when patients with normal blood pressure or hypertension were considered separately. However, a highly significant positive correlation was found between 125I-apoAI/high density lipoprotein fractional catabolic rate and insulin concentration in the entire population (r=0.72, p<0.001). In conclusion, the patients with mild hypertension studied were hyperinsulinemic, had a faster fractional catabolic rate of 125I-apoAI/high density lipoprotein, and a lower high density lipoprotein-cholesterol concentration. It is suggested that the changes seen in high density lipoprotein-cholesterol concentration and 125I-apoAI/high density lipoprotein fractional catabolic rates were secondary to the hyperinsulinemia and not due to the high blood pressure per se.

AB - Although hyperinsulinemia and decreased high density lipoprotein cholesterol concentration can occur in patients with hypertension, there is no information available concerning the dynamic state of high density lipoprotein metabolism. To address this issue, we quantified high density lipoprotein turnover in 12 patients with mild hypertension and 11 matched subjects with normal blood pressure. Patients with high blood pressure had lower high density lipoprotein cholesterol concentrations. Fractional catabolic rates of 125I-apolipoprotein AI (apoAI)/high density lipoprotein were faster in patients with hypertension (0.36±0.02 versus 0.26±0.02 I/day, p<0.001). Total synthetic rates of apoAI were also significantly greater in patients with high blood pressure (17.4±1.1 versus 13.2±0.6 mg/kg/day, p<0.001). Although significant correlation was observed between blood pressure and fractional catabolic rate of 125I-apoAI/high density lipoprotein in the experimental population (r=0.52, p<0.01), no relation was found when patients with normal blood pressure or hypertension were considered separately. However, a highly significant positive correlation was found between 125I-apoAI/high density lipoprotein fractional catabolic rate and insulin concentration in the entire population (r=0.72, p<0.001). In conclusion, the patients with mild hypertension studied were hyperinsulinemic, had a faster fractional catabolic rate of 125I-apoAI/high density lipoprotein, and a lower high density lipoprotein-cholesterol concentration. It is suggested that the changes seen in high density lipoprotein-cholesterol concentration and 125I-apoAI/high density lipoprotein fractional catabolic rates were secondary to the hyperinsulinemia and not due to the high blood pressure per se.

KW - Apolipoproteins

KW - Blood pressure

KW - Essential hypertension

KW - High density lipoprotein kinetics

KW - High density lipoproteins

KW - Hyperinsulinemia

UR - http://www.scopus.com/inward/record.url?scp=0026088833&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026088833&partnerID=8YFLogxK

M3 - Article

VL - 17

SP - 386

EP - 393

JO - Hypertension

JF - Hypertension

SN - 0194-911X

IS - 3

ER -